Fig. 1From: Real-world advantage and challenge of post-autologous stem cell transplantation MRD negativity in high-risk patients with double-hit multiple myelomaThe association of individual HRCA or the number of HRCA with clinical risk groups. (A) The distribution of individual HRCA or the number of HRCA by ISS sorted by the proportion of patients; (B) The contribution of individual HRCA or the number of HRCA to relapse sorted by the proportion of patients, with a breakdown of PFS over ≤ 18 months/ 18–36 months/>36 months, or no progression. HR, high risk; HRCA, high-risk cytogenetics; PD, progressive diseaseBack to article page